Eosinophilic pustular folliculitis effectively treated with recombinant interferon-γ: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells
- 1 April 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 134 (4) , 766-772
- https://doi.org/10.1046/j.1365-2133.1996.93806.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Human TH1 and TH2 subsets: doubt no morePublished by Elsevier ,2004
- Elevated production of interleukin-4 and interleukin-5 by T cells in a child with idiopathic hypereosinophilic syndromeJournal of Allergy and Clinical Immunology, 1994
- Induction of Intercellular Adhesion Molecule 1 (ICAM-1) Expression in Normal Human Eosinophils by Inflammatory CytokinesJournal of Investigative Dermatology, 1993
- Recombinant interferon gamma therapy for atopic dermatitisJournal of the American Academy of Dermatology, 1993
- Treatment of systemic sclerosis with γ-interferonBritish Journal of Dermatology, 1992
- Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils.The Journal of Experimental Medicine, 1991
- Eosinophilia in transgenic mice expressing interleukin 5.The Journal of Experimental Medicine, 1990
- Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Journal of Clinical Investigation, 1986
- Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells.The Journal of Experimental Medicine, 1986
- Eosinophilic pustular folliculitis. Studies on possible chemotactic factors involved in the formation of pustulesBritish Journal of Dermatology, 1986